Depo-Provera Class Action Lawsuits

Depo-Provera Lawsuit Litigation Updates

November 5, 2024

• New Depo Provera Lawsuit Filed in California: A woman from Fontana, California, has filed a lawsuit alleging that the contraceptive injection Depo-Provera caused her to develop a life-threatening meningioma brain tumor. The lawsuit claims that Pfizer and Viatris, the manufacturers of Depo-Provera, failed to warn about this risk despite existing scientific evidence linking the drug to meningiomas. The plaintiff used Depo-Provera from 1999 to 2018 and subsequently underwent surgery to remove the tumor. This case, filed in the Northern District of California, could potentially influence the location of a future Depo Provera MDL, should one be established.

October 22, 2024

• Depo-Provera & Meningioma Risk: Discrepancy in Warning Labels Raises Concerns: A discrepancy in warning labels for Depo-Provera between the U.S. and Europe is raising concerns about transparency and patient safety. While the European label includes a warning about the potential risk of meningiomas (a type of brain tumor), the U.S. label does not, despite research linking hormonal contraceptives to this condition. This difference in labeling raises questions about why the FDA has not mandated a similar warning in the U.S. and whether Pfizer, the manufacturer of Depo-Provera, is adequately informing patients about potential risks.

Is Depo-Provera Harmful?

Depo-Provera, a widely used contraceptive injection, is facing questions about a possible link between its use and the development of meningiomas, a type of brain tumor. This has led to increased inquiries from women who have used Depo-Provera and later experienced health problems.

But you don't have to face this alone. You have rights. At Injury Claims, we connect you with experienced attorneys who will advocate for you and help you pursue the compensation you deserve if you’ve been affected by Depo-Provera’s harmful side effects.

FILL OUT THE FORM FOR MORE INFORMATION

Depo-Provera Use and Meningioma Development

Recent studies have suggested a possible association between long-term Depo-Provera use and an increased risk of meningioma. Meningiomas are tumors that form in the membranes surrounding the brain and spinal cord. While often slow-growing and benign, they can cause a range of neurological symptoms depending on their size and location.

The possible link between Depo-Provera and meningiomas raises questions about the adequacy of information provided to patients regarding the medication's risks.

What Is a Meningioma?

A meningioma is a tumor that arises from the meninges, the protective layers of tissue that surround the brain and spinal cord.

There are three types of meningiomas:

• Benign. These are the most common type and are non-cancerous.
• Atypical. These are faster-growing than benign meningiomas and have a higher chance of recurring after treatment.
• Malignant. These are cancerous and are the least common type.

Meningiomas can cause a variety of symptoms, including:

• Headaches,
• Vision changes,
• Hearing loss,
• Weakness or numbness in the arms or legs, and
• Seizures.

SEE IF YOU QUALIFY FOR A DEPO-PROVERA BRAIN TUMOR LAWSUIT

Symptoms of a Meningioma

Meningiomas often grow slowly and may not cause noticeable symptoms for years. However, as they increase in size, they can press on the brain or spinal cord, leading to various neurological problems.

Common symptoms include:

• Changes in vision, such as blurred or double vision;
• Headaches, often worse in the morning;
• Hearing loss;
• Memory problems;
• Weakness or numbness in the arms or legs; and
• Seizures.

Depo-Provera Lawsuits

Women who developed meningiomas after using Depo-Provera are seeking legal action against the drug's manufacturer, alleging a failure to adequately warn about this potential risk. These lawsuits aim to hold the manufacturer accountable and secure compensation for medical expenses, lost income, and pain and suffering.

CLICK HERE TO SEE IF YOU QUALIFY TO FILE A CLAIM